Streetbeat News

Analyst Ratings

MNST

MKM Partners analyst Sean McGowan maintains a Neutral rating on Monster Beverage (NASDAQ:MNST) and raises the price target from $55 to $57.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:39 pm

GEO

Wedbush analyst Jay McCanless has maintained an Outperform rating on GEO Group (NYSE:GEO) and raised the price target from $11 to $12.5.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 1:39 pm

BCO

Goldman Sachs analyst George Tong maintains a Buy rating on Brink's (NYSE:BCO) and raises the price target from $81 to $92.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:38 pm

RBLX

Wedbush analyst Nick McKay has upgraded Roblox (NYSE:RBLX) from Neutral to Outperform and announced a price target of $37.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 1:38 pm

SONX

Goldman Sachs analyst Nathan Rich has maintained a 'Buy' rating on Sonendo (NYSE:SONX), but lowered the price target from $2 to $1.75.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:37 pm

SONO

DA Davidson analyst Tom Forte maintains a 'Buy' rating on Sonos (NASDAQ:SONO) and raises the price target from $22 to $24.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:37 pm

OMIC

Goldman Sachs analyst Matthew Sykes has maintained a Neutral rating on Singular Genomics Sys (NASDAQ:OMIC) and lowered the price target from $1.15 to $1.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:36 pm

ALRM

MKM Partners analyst Darren Aftahi maintains a 'Buy' rating on Alarm.com Holdings (NASDAQ:ALRM) and raises the price target from $59 to $61.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 1:35 pm

RIVN

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Rivian Automotive (NASDAQ:RIVN) and raised the price target from $18 to $23.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 1:34 pm

ADMA

Raymond James analyst Elliot Wilbur maintains a Strong Buy rating on ADMA Biologics (NASDAQ:ADMA) and raises the price target from $5 to $6.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 1:34 pm